Results 181 to 190 of about 61,158,239 (269)
[Labor and social repercussions on the quality of life of breast cancer survivors]. [PDF]
Palacín-Melús SE +5 more
europepmc +1 more source
ABSTRACT KAI1 C‐terminal interacting tetraspanin (KITENIN) is an emerging oncogenic regulator associated with tumorigenesis, metastasis, therapeutic resistance, and poor clinical outcomes. Mechanistically, KITENIN promotes tumor cell proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT) by activating oncogenic pathways ...
Niaz Mahmood Tanoy +8 more
wiley +1 more source
[Inconsistency in the effective implementation of care plans for breast cancer survivors]. [PDF]
López Cornudella L, Lozano A.
europepmc +1 more source
Role of SoxE transcription factors in development and disease
Abstract Sox8, Sox9, and Sox10 arose by multiple rounds of genome duplications from a single SoxE gene in ancestral vertebrates. In this review, we will briefly discuss the molecular structure and function of SoxE transcription factors and their evolutionary origin. We will then discuss their expression, function, and developmental disorders.
Merin Lawrence, Gerhard Schlosser
wiley +1 more source
Construction and assessment of the "Almanac for Women with Breast Cancer": convergent care research. [PDF]
Teófilo KR +6 more
europepmc +1 more source
Abstract When I was 12, my family told me a story about their community falling apart and coming together, a time when someone tried putting a nuclear facility in their (our?) hometown. Since we moved when I was too young to remember, the story had little significance until I embarked on a “hometown” ethnographic journey for my dissertation.
Chandler L. Classen
wiley +1 more source
Survival time analysis in women with breast cancer using distributional regression models. [PDF]
Lima IDS +6 more
europepmc +1 more source
Prognostic Impact of AGR3 Protein Expression in Breast Cancer: A Systematic Review and Meta-analysis. [PDF]
Moraes CL +5 more
europepmc +1 more source
[Determinants in the quality of life of breast cancer survivors]. [PDF]
López-Salas M +5 more
europepmc +1 more source
[Time intervals for diagnosis and treatment in breast cancer patients]. [PDF]
Sánchez Galindo B +5 more
europepmc +1 more source

